{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T09:07:21Z","timestamp":1753520841390,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI18C0844"],"award-info":[{"award-number":["HI18C0844"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The time at which hypertension treatment should be initiated for different age groups and sexes remains controversial. We aimed to determine whether the association between blood pressure (BP) and major adverse cardiovascular events (MACE) varies with age and sex. This study enrolled 327,328 subjects who had not taken antihypertensive medication in the Korean National Health Service-National Health Screening Cohort between 2002 and 2003. Participants were categorized into four groups according to 2017 American College of Cardiology\/American Heart Association hypertension guideline. Primary outcome was MACE characterized by cardiovascular mortality, myocardial infarction, unstable angina, and stroke. During a 10-year follow-up, a significant increase in MACE risk was observed from the stage 1 hypertension group (hazard ratio [HR], 1.23; 95% CI 1.15\u20131.32; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) in time-varying Cox analysis. This relationship was persistent in subjects aged &lt;\u200970\u00a0years, but increased MACE risk was observed only in the stage 2 hypertension group in \u2265\u200970\u00a0years (HR, 1.52; 95% CI 1.32\u20131.76, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). When categorized as per sex, both men and women showed significant MACE risk from stage 1 hypertension. However, on comparing the sexes after stratifying by age, a significantly increased risk of MACE was shown from stage 1 hypertension in men aged &lt;\u200950\u00a0years, but from stage 2 hypertension in men aged \u2265\u200950\u00a0years. Meanwhile, increased MACE risk was observed from stage 2 hypertension in women aged &lt;\u200960\u00a0years, but from stage 1 hypertension in women aged \u2265\u200960\u00a0years. Thus, young male subjects had higher MACE risk than young female subjects, but this difference gradually decreased with age and there was no difference between sexes in subjects aged \u2265\u200970\u00a0years. Therefore, our results suggest that hypertension treatment initiation may need to be individualized depending on age and sex.<\/jats:p>","DOI":"10.1038\/s41598-020-78641-3","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T11:52:15Z","timestamp":1607514735000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Age and sex specific target of blood pressure for the prevention of cardiovascular event among the treatment naive hypertensive patients"],"prefix":"10.1038","volume":"10","author":[{"given":"Hyoungnae","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seulbi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunhee","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soon Hyo","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Seok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunjin","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Cheol","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyung Jung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Ryeol","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"78641_CR1","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1007\/s11906-013-0403-y","volume":"15","author":"X Guo","year":"2013","unstructured":"Guo, X. et al. Association between pre-hypertension and cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Curr. Hypertens. Rep. 15, 703\u2013716 (2013).","journal-title":"Curr. Hypertens. Rep."},{"key":"78641_CR2","doi-asserted-by":"publisher","first-page":"e001519","DOI":"10.1161\/JAHA.114.001519","volume":"4","author":"Y Huang","year":"2015","unstructured":"Huang, Y. et al. Prehypertension and the risk of coronary heart disease in Asian and Western populations: A meta-analysis. J. Am. Heart Assoc. 4, e001519 (2015).","journal-title":"J. Am. Heart Assoc."},{"key":"78641_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.ahj.2013.10.023","volume":"167","author":"Y Huang","year":"2014","unstructured":"Huang, Y. et al. Association of all-cause and cardiovascular mortality with prehypertension: A meta-analysis. Am. Heart J. 167, 160-168.e161 (2014).","journal-title":"Am. Heart J."},{"key":"78641_CR4","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1741-7015-11-177","volume":"11","author":"Y Huang","year":"2013","unstructured":"Huang, Y. et al. Prehypertension and incidence of cardiovascular disease: a meta-analysis. BMC Med. 11, 177 (2013).","journal-title":"BMC Med."},{"key":"78641_CR5","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"Wright, J. T. Jr. et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103\u20132116 (2015).","journal-title":"N. Engl. J. Med."},{"key":"78641_CR6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"PK Whelton","year":"2018","unstructured":"Whelton, P. K. et al. ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive summary: A report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension (Dallas, Tex.: 1979) 71, 1269\u20131324 (2018).","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"78641_CR7","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1097\/HJH.0000000000001961","volume":"36","author":"B Williams","year":"2018","unstructured":"Williams, B. et al. 2018 Practice Guidelines for the management of arterial hypertension of the European Society of Hypertension and the European Society of Cardiology: ESH\/ESC Task Force for the Management of Arterial Hypertension. J. Hypertens. 36, 2284\u20132309 (2018).","journal-title":"J. Hypertens."},{"key":"78641_CR8","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1001\/jama.2017.18605","volume":"318","author":"P Greenland","year":"2017","unstructured":"Greenland, P. & Peterson, E. The new 2017 ACC\/AHA guidelines \u201cUp the Pressure\u201d on diagnosis and treatment of hypertension. JAMA 318, 2083\u20132084 (2017).","journal-title":"JAMA"},{"key":"78641_CR9","doi-asserted-by":"publisher","first-page":"287","DOI":"10.7326\/M17-3103","volume":"168","author":"JB Cohen","year":"2018","unstructured":"Cohen, J. B. & Townsend, R. R. The ACC\/AHA 2017 hypertension guidelines: Both too much and not enough of a good thing?. Ann. Intern. Med. 168, 287\u2013288 (2018).","journal-title":"Ann. Intern. Med."},{"key":"78641_CR10","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1001\/jama.2016.7050","volume":"315","author":"JD Williamson","year":"2016","unstructured":"Williamson, J. D. et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged \u2265\u200975\u00a0years: A randomized clinical trial. JAMA 315, 2673\u20132682 (2016).","journal-title":"JAMA"},{"key":"78641_CR11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/nrneph.2017.189","volume":"14","author":"KMM Colafella","year":"2018","unstructured":"Colafella, K. M. M. & Denton, K. M. Sex-specific differences in hypertension and associated cardiovascular disease. Nat. Rev. Nephrol. 14, 185\u2013201 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"78641_CR12","doi-asserted-by":"publisher","first-page":"e016640","DOI":"10.1136\/bmjopen-2017-016640","volume":"7","author":"SC Seong","year":"2017","unstructured":"Seong, S. C. et al. Cohort profile: the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) in Korea. BMJ Open 7, e016640 (2017).","journal-title":"BMJ Open"},{"key":"78641_CR13","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.jclinepi.2004.03.012","volume":"57","author":"V Sundararajan","year":"2004","unstructured":"Sundararajan, V. et al. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J. Clin. Epidemiol. 57, 1288\u20131294 (2004).","journal-title":"J. Clin. Epidemiol."},{"key":"78641_CR14","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/07853890.2018.1492146","volume":"50","author":"HJ Oh","year":"2018","unstructured":"Oh, H. J. et al. Association of blood pressure components with mortality and cardiovascular events in prehypertensive individuals: A nationwide population-based cohort study. Ann. Med. 50, 443\u2013452 (2018).","journal-title":"Ann. Med."},{"key":"78641_CR15","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/pan\/mpi014","volume":"14","author":"T Brambor","year":"2006","unstructured":"Brambor, T., Clark, W. R. & Golder, M. Understanding interaction models: Improving empirical analyses. Polit. Anal. 14, 63\u201382 (2006).","journal-title":"Polit. Anal."},{"key":"78641_CR16","unstructured":"R Core Team. R: A language and environment for statistical computing https:\/\/www.R-project.org\u00a0(2020)."},{"key":"78641_CR17","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1001\/jama.2018.13551","volume":"320","author":"Y Yano","year":"2018","unstructured":"Yano, Y. et al. Association of Blood Pressure Classification in Young Adults using the 2017 American College of Cardiology\/American Heart Association Blood Pressure Guideline with cardiovascular events later in life. JAMA 320, 1774\u20131782 (2018).","journal-title":"JAMA"},{"key":"78641_CR18","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1001\/jama.2018.16501","volume":"320","author":"JS Son","year":"2018","unstructured":"Son, J. S. et al. Association of Blood Pressure Classification in Korean Young Adults According to the 2017 American College of Cardiology\/American Heart Association Guidelines With Subsequent Cardiovascular Disease Events. JAMA 320, 1783\u20131792 (2018).","journal-title":"JAMA"},{"key":"78641_CR19","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/HYPERTENSIONAHA.117.09801","volume":"70","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. & Moran, A. E. Trends in the prevalence, awareness, treatment, and control of hypertension among young adults in the United States, 1999\u20132014. Hypertension (Dallas, Tex.: 1979) 70, 736\u2013742 (2017).","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"78641_CR20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40885-018-0098-0","volume":"24","author":"HC Kim","year":"2018","unstructured":"Kim, H. C. & Cho, M. C. Korea hypertension fact sheet 2018. Clin. Hypertens. 24, 13 (2018).","journal-title":"Clin. Hypertens."},{"key":"78641_CR21","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","volume":"383","author":"E Rapsomaniki","year":"2014","unstructured":"Rapsomaniki, E. et al. Blood pressure and incidence of twelve cardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet (London, England) 383, 1899\u20131911 (2014).","journal-title":"Lancet (London, England)"},{"key":"78641_CR22","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1291\/hypres.31.2115","volume":"31","author":"JATOS Study Group","year":"2008","unstructured":"JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens. Res. Off. J. Japan. Soc. Hypertens. 31, 2115\u20132127 (2008).","journal-title":"Hypertens. Res. Off. J. Japan. Soc. Hypertens."},{"key":"78641_CR23","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","volume":"56","author":"T Ogihara","year":"2010","unstructured":"Ogihara, T. et al. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in elderly isolated systolic hypertension study. Hypertension (Dallas, Tex.: 1979) 56, 196\u2013202 (2010).","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"key":"78641_CR24","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","volume":"374","author":"EM Lonn","year":"2016","unstructured":"Lonn, E. M. et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N. Engl. J. Med. 374, 2009\u20132020 (2016).","journal-title":"N. Engl. J. Med."},{"key":"78641_CR25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.amjcard.2018.05.046","volume":"122","author":"R Ochoa-Jimenez","year":"2018","unstructured":"Ochoa-Jimenez, R., Viquez-Beita, K., Daluwatte, C. & Zusterzeel, R. Sex differences of patients with systemic hypertension (from the analysis of the systolic blood pressure intervention trial [SPRINT]). Am. J. Cardiol. 122, 985\u2013993 (2018).","journal-title":"Am. J. Cardiol."},{"key":"78641_CR26","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1097\/HJH.0b013e3281c49da5","volume":"25","author":"TW Hansen","year":"2007","unstructured":"Hansen, T. W. et al. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: A meta-analysis of 7030 individuals. J. Hypertens. 25, 1554\u20131564 (2007).","journal-title":"J. Hypertens."},{"key":"78641_CR27","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1097\/HJH.0000000000000355","volume":"32","author":"GC Roush","year":"2014","unstructured":"Roush, G. C. et al. Prognostic impact from clinic, daytime, and night-time systolic blood pressure in nine cohorts of 13,844 patients with hypertension. J. Hypertens. 32, 2332\u20132340 (2014) (discussion 2340).","journal-title":"J. Hypertens."},{"key":"78641_CR28","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1161\/HYPERTENSIONAHA.118.11068","volume":"71","author":"HH Jung","year":"2018","unstructured":"Jung, H. H., Park, J. I. & Jeong, J. S. Blood pressure-related risk among users versus nonusers of antihypertensives: A population-based cohort in Korea. Hypertension (Dallas, Tex.: 1979) 71, 1047\u20131055 (2018).","journal-title":"Hypertension (Dallas, Tex.: 1979)"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78641-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78641-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:39:31Z","timestamp":1670373571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-78641-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["78641"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-78641-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2020,12,9]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21538"}}